NCT05862857Completed
The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 1)
Innovative Strategies to Promote Biomedical HIV Prevention Uptake and Retention Among High-risk Adults at Drinking Venues in Kenya and Uganda
Source: ClinicalTrials.gov · Last updated 11 Mar 2026
Brief summary (registry, in English)
This study will test innovative interventions to increase uptake and use of biomedical HIV prevention options by engaging women and men at drinking venues in rural Kenya and Uganda in care, while gaining insights into the facilitators, barriers, and cost-effectiveness of these approaches.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 9375 (actual)
- First submitted
- 8 May 2023
- Start date
- 13 Jul 2023
- Primary completion date
- 3 Feb 2025
- Lead sponsor
- University of California, San Francisco
- Diseases
- HIV
- NCT number
- NCT05862857
What you commit to
- Study type: Interventional
- Participants enrolled: 9375
- From 13 Jul 2023 to the primary completion date, 3 Feb 2025
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- none
Criteria the registry did not label
- Participant Inclusion Criteria:
- adult (≥18 years)
- patron or worker at a drinking venue within the study community
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kenya Medical Research Institute (KEMRI) Coordinator of this site? Confirm its status | Mbita | Kenya | Unknown status |
| Infectious Diseases Research Collaboration (IDRC) Coordinator of this site? Confirm its status | Mbarara | Uganda | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.